Clinical acceptance and market adoption
Revenue depends on surgeons, hospitals, and providers adopting the products in routine care.
- Scope
- CellerateRX Surgical, BIASURGE, bone fusion products
- Materiality
- high
Sanara MedTech Inc.
Sanara MedTech Inc. is a U.S.-based medical technology company focused on products and services for surgical care, chronic wound care, and skincare. Its business is organized around Sanara Surgical and THP, combining surgical-site products, bone fusion products, and value-based wound care services across the care continuum in the United States.
10,9 %
92,7 %
−36,4 %
+19,0 %
1.80
1.59
| % | |
|---|---|
| Soft tissue repair products | 88% Collagen-based and surgical-site products used to support wound healing and irrigation in sterile settings. |
| Bone fusion products | 12% Biologic and matrix products used in orthopedic and surgical bone grafting and fusion procedures. |
| Value-based wound care services | 0% THP-related wound care and skincare services and programs delivered through provider partnerships. |
| R&D and pipeline technologies | 0% Internal development work and product pipeline activities led by Rochal Technologies. |
The company sells primarily to hospitals and other acute care facilities that use its products in surgical and sterile...
- Hospitals and acute care facilitiesprimary
Buy soft tissue repair and bone fusion products for use in operating rooms and sterile environments.
- Wound care provider groupsprimary
Adopt THP value-based wound care and skincare services to support patient management across care settings.
- Surgeons and procedural clinicianssecondary
Influence product selection for surgical-site management, irrigation, and bone grafting applications.
- Healthcare systems and provider networkssecondary
Evaluate products and services based on clinical outcomes, workflow fit, and total cost of care.
Sanara MedTech operates primarily in the United States, where it sells through an expanding independent distribution...
- •United States is the core commercial market
- •Sales are expanded through independent distribution networks
- •Growth depends on penetration in new and existing U.S. markets
- •Operations and clinical adoption are centered in U.S. healthcare facilities
The company is building a broader platform across surgical products, wound care, and skincare services, with THP...
01
Expand THP and value-based wound care servicesshort-term
This creates a services layer alongside products and broadens the company’s care continuum offering.
02
Increase penetration of surgical productsmedium-term
Higher adoption of core products supports scale in hospitals and acute care facilities.
03
Build the product and technology pipelinemedium-term
New products and technologies can extend the portfolio and support future growth.
04
Pursue acquisitions and strategic partnershipsmedium-term
External growth can add capabilities, provider access, and service offerings.
The business depends on clinical acceptance, reimbursement dynamics, and the ability to commercialize licensed and...
Reimbursement and regulatory changes
Healthcare purchasing and service economics are influenced by labeling, marketing, and reimbursement rules.
- Scope
- Wound care and skincare services
- Materiality
- high
Debt and liquidity management
The company uses credit facilities and equity financing to fund growth and acquisitions.
- Scope
- CRG Term Loan and future capital needs
- Materiality
- high
Acquisition and integration execution
The THP strategy relies on acquisitions and partner relationships that may not deliver expected benefits.
- Scope
- CarePICS and future acquisitions
- Materiality
- high
Dependence on third-party licensed products and supply
Manufacturing, licensing, and distribution disruptions can interrupt sales and margins.
- Scope
- Licensed products and external manufacturers
- Materiality
- medium
Product quality and intellectual property
Defects or IP disputes can limit commercialization and damage customer trust.
- Scope
- Surgical and bone fusion portfolio
- Materiality
- medium
Revenue recognition timing
Quarterly revenue and gross profit
Acquisition accounting and earnout liabilities
Goodwill, intangibles, and noncash fair value gains/losses
Intangible asset amortization
Operating expenses and earnings
Related-party transactions
Balance sheet and governance transparency
Estimates and purchase price allocation
Acquisition accounting and future impairment risk
Celularity Inc
CELU · Pharmaceutical Preparations
Bicara Therapeutics Inc.
BCAX · Pharmaceutical Preparations
LENSAR, Inc.
LNSR · Surgical & Medical Instruments & Apparatus
Solana Co
HSDT · Finance Services
Solana Co is a U.S.-based public company organized around a Solana digital asset treasury strategy, with Solana (SOL) as its primary treasury reserve asset.
REGENEREX PHARMA, INC.
Pharmaceutical Preparations
Vicarious Surgical Inc.
RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
: 29/04/2026